Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies

被引:0
|
作者
Schreiber, S. [1 ]
Loftus, E. V., Jr. [2 ]
Maaser, C. [3 ]
Danese, S. [4 ,5 ]
Rudolph, C. [6 ]
Jongen, R. [6 ]
De Haas, A. [6 ]
Oortwijn, A. [6 ]
Vermeire, S. [7 ]
机构
[1] Univ Kiel, Med 1, Kiel, Germany
[2] Mayo Clin, Coll Med & Sci, Div Gastroenterol & Hepatol, Rochester, MN USA
[3] Hosp Luneburg, Outpatients Dept Gastroenterol, Luneburg, Germany
[4] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[5] San Raffaele Univ, Vita Salute, Milan, Italy
[6] Galapagos Nv, Leiden, Netherlands
[7] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
DOP37
引用
收藏
页码:I085 / I087
页数:3
相关论文
共 50 条
  • [41] Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme
    Raine, Tim
    Ishiguro, Yoh
    Rubin, David T.
    Finney-Hayward, Tricia
    Vladea, Ramona
    Liu, John
    Phillips, Charles
    Cheng, Erica
    Targownik, Laura
    Loftus Jr, Edward, V
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (05): : 695 - 707
  • [42] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
    Vijay Yajnik
    Nabeel Khan
    Marla Dubinsky
    Jeffrey Axler
    Alexandra James
    Brihad Abhyankar
    Karen Lasch
    Advances in Therapy, 2017, 34 : 542 - 559
  • [43] Ozanimod Efficacy and Safety in Older Patients With Ulcerative Colitis: A Post Hoc Analysis From True North
    Khan, Nabeel
    Irving, Peter
    Blumenstein, Irina
    Horst, Sara
    Ahmad, Harris
    Lawlor, Garrett
    Hobbs, Vanessa
    Jain, Anjali
    Memaj, Arteid
    Ananthakrishnan, Ashwin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S25 - S25
  • [44] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age
    Yajnik, Vijay
    Khan, Nabeel
    Dubinsky, Marla
    Axler, Jeffrey
    James, Alexandra
    Abhyankar, Brihad
    Lasch, Karen
    ADVANCES IN THERAPY, 2017, 34 (02) : 542 - 559
  • [45] Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
    Feagan, Brian G.
    Danese, Silvio
    Loftus, Edward V., Jr.
    Vermeire, Severine
    Schreiber, Stefan
    Ritter, Timothy
    Fogel, Ronald
    Mehta, Rajiv
    Nijhawan, Sandeep
    Kempinski, Radoslaw
    Filip, Rafal
    Hospodarskyy, Ihor
    Seidler, Ursula
    Seibold, Frank
    Beales, Ian L. P.
    Kim, Hyo Jong
    McNally, John
    Yun, Chohee
    Zhao, Sally
    Liu, Xiaopeng
    Hsueh, Chia-Hsiang
    Tasset, Chantal
    Besuyen, Robin
    Watanabe, Mamoru
    Sandborn, William J.
    Rogler, Gerhard
    Hibi, Toshifumi
    Peyrin-Biroulet, Laurent
    LANCET, 2021, 397 (10292): : 2372 - 2384
  • [46] Efficacy of ozanimod in vedolizumab-exposed patients with ulcerative colitis: a phase 3 True North post hoc analysis
    Sands, B. E.
    Jain, A.
    Ahmad, H. A.
    Osterman, M.
    Memaj, A.
    Canavan, J. B.
    Axelrad, J. E.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 507 - 508
  • [47] Efficacy of Ozanimod in Vedolizumab-Exposed Patients With Ulcerative Colitis: A Phase 3 True North Post Hoc Analysis
    Sands, Bruce E.
    Jain, Anjali
    Ahmad, Harris A.
    Osterman, Mark
    Memaj, Arteid
    Canavan, James B.
    Axelrad, Jordan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S593 - S594
  • [48] CORTICOSTEROID-FREE REMISSION OF ULCERATIVE COLITIS WITH FILGOTINIB MAINTENANCE THERAPY: POST-HOC ANALYSIS OF THE SELECTION STUDY
    Morison, Ben
    Loftus, Edward V.
    Vermeire, Severine
    Feagan, Brian
    Yun, Chohee
    Hsieh, Jeremy
    Liu, Xiaopeng
    Zhao, Sally
    Moerch, Ulrik
    Sandborn, William J.
    Hibi, Toshifumi
    GUT, 2021, 70 : A92 - A92
  • [49] FILGOTINIB PROVIDES IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: SF-36 RESULTS FROM THE PHASE 2B/3 SELECTION STUDY
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Feagan, Brian G.
    Vermeire, Severine
    Hasegawa, Ken
    Hsieh, Jeremy
    Yun, Chohee
    Zhao, Sally
    Liu, Xiaopeng
    Khalid, Javaria M.
    Schreiber, Stefan
    GASTROENTEROLOGY, 2021, 160 (06) : S558 - S558
  • [50] Efficacy and safety of ozanimod in older patients with ulcerative colitis (UC): post hoc analysis of the True North study
    Chandwe, Kanta
    Bwakura-Dangarembizi, Mutsa
    Amadi, Beatrice
    Tawodzera, Gertrude
    Murch, Simon
    Hill, Susan
    Playford, Ray
    VanBuskirk, Kelley
    Prendergast, Andrew
    Kelly, Paul
    GUT, 2023, 72 (SUPPL_2) : A107 - A107